Four (4) each Genomic Sequencing Systems

This contract involves the procurement of four Illumina MiSeq i100 Plus desktop genomic sequencing systems to be used by the FDA’s Human Foods Program. These systems are intended to replace outdated sequencers currently in use, ensuring continuity in sequencing methods through compatibility with proprietary flow cells, reagents, software licenses, and manufacturer-supported components. The acquisition supports the FDA's mission by providing advanced, high-throughput genomic sequencing capabilities necessary for effective food safety surveillance, regulatory compliance, and the development of innovative genomic applications. The solicitation was posted on June 15, 2026, with a response deadline of June 26, 2026, and is managed by the FDA Office of Acquisition and Grant Services under the Department of Health and Human Services. This is a combined type contract with no set-aside restrictions, classified under NAICS code 334516. The purchase is location-independent, but managed through the FDA office in Rockville, Maryland. The contract emphasizes the importance of maintaining existing sequencing technology standards and proprietary systems to ensure mission-driven project continuity in detecting and characterizing foodborne pathogens.